¼¼Æ÷ ³»,¿ÜÀÇ communication ±âÀÛ°ú ´ë»ç Á¶Àý¿¡¼ °¢°¢ÀÇ ¿ªÇÒ¿¡ ´ëÇÑ review¸¦ Á¦°øÇÕ´Ï´Ù.
Pre-mixed ŸÀÔÀ¸·Î »ç¿ëÀÌ Æí¸®ÇÑ Protease¿Í Phosphatase Inhibitor Cocktail Á¦Ç°À» ¼Ò°³ÇÕ´Ï´Ù.
°íǰÁúÀÇ ¾à 2,300¿©Á¾ÀÇ Calbiochem Inhibitor¸¦ ¼Ò°³ÇÕ´Ï´Ù.
G-Proteins ÃøÁ¤ ŰƮ¿Í Motor ´Ü¹éÁú, tubulin ´Ü¹éÁú Á¦Ç°µéÀÌ ¼ö·ÏµÇ¾î ÀÖ´Â ¹Ì´Ï Ä«´Þ·Î±× ÀÔ´Ï´Ù.
¾à 3400¿©Á¾ÀÇ Àü±â¿µµ¿, ¸é¿ªÇÐ, ºÐÀÚ»ý¹°ÇÐ °ü·Ã °í¸¶Á¦Ç°ÀÌ ¼ö·ÏµÇ¾î ÀÖ´Â °í¸¶ Á¾ÇÕ Ä«Å»·Î±× ÀÔ´Ï´Ù.
Stem Cell Culture¿¡ °ü·ÃµÈ Á¦Ç°ÀÌ ¼ö·ÏµÈ īŻ·Ï ÀÔ´Ï´Ù.
Oxidative & Cellular Stress¿¡ ´ëÇÑ assay kitÀ» ¼Ò°³ÇÕ´Ï´Ù.
Milliplex kit À̿ܿ¡µµ ´Ù¾çÇÑ antibody¿Í kit, infectious disease¿¡ »ç¿ëµÇ´Â antibodyµîÀÌ ¼Ò°³µÇ¾î ÀÖ´Â Á¦Ç°°¡ÀÌµå ºÏÀÔ´Ï´Ù.
¿©·¯ ÆÄÀå´ëÀÇ Çü±¤À» ÀÌ¿ëÇÏ¿©, ´Ù¾çÇÑ ½ÇÇè¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
Progenitor Cell Culture¸¦ À§ÇÑ Media°¡ ½Ç·ÁÀÖ´Â ºê·Î¼Å ÀÔ´Ï´Ù.
Cell signaling¿¡ ÇÊ¿äÇÑ inhibitor, substrate ¹× °¢Á¾ receptor¿¡ ÀÛ¿ëÇÏ´Â agonist, antagonistµîÀÌ ¼ö·ÏµÇ¾î ÀÖ½À´Ï´Ù.
Epitope Tags & Fusion Protein Partners, Cytoskeletal & Cell Surface Protein, Transcription Factor & Signal Transduction, Cellular Markers µî¿¡ ´ëÇÑ Ç×ü°¡ ¼ö·ÏµÇ¾î ÀÖ½À´Ï´Ù.
kidney damage¸¦ È®ÀÎÇϱâ À§ÇÑ NGAL kitµîÀ» Á¦°øÇÕ´Ï´Ù.
Cytokine Á¦Ç°ÀÌ ¼ö·ÏµÇ¾î ÀÖ½À´Ï´Ù.
Multi-Analyte detectionÀ» À§ÇÑ Luminex system¿¡ ´ëÇÑ ¼³¸íÀÌ ¼ö·ÏµÇ¾î ÀÖ½À´Ï´Ù
Horizontal Àü±â¿µµ¿ÀåÄ¡¿Í pre-cast horizontal gel¿¡ ´ëÇÑ ³»¿ëÀÌ ¼ö·ÏµÇ¾î ÀÖ½À´Ï´Ù.
Metabolism, enzyme activity, Ion assayµî¿¡ ´ëÇÑ kit¸¦ Á¦°øÇÕ´Ï´Ù.
Labeling È¿°ú°¡ ¶Ù¾î³ ÇÙ»ê ¹× ´Ü¹éÁú labeling¿ë fluorescent CF dyes¸¦ ¼Ò°³ÇÕ´Ï´Ù.
°í¸¶¿¡¼ »ý»êÇÏ´Â Direct PCR Á¦Ç°, ELISA Kit, Çü±¤½Ã¾àµî¿¡ ´ëÇÑ ÀÚ·á°¡ ¼ö·ÏµÈ ¹Ì´ÏīŻ·Î±× ÀÔ´Ï´Ù.
Stem cell, media¹× supplement¿Í ´Ù¾çÇÑ assay kitµîÀÌ ¼Ò°³µÇ¾î ÀÖ´Â ¹Ì´ÏÄ«´Þ·Î±×ÀÔ´Ï´Ù.
°í¸¶¿¡¼ Ãë±ÞÇÏ´Â ´Ù¾çÇÑ ºÐ¾ßÀÇ ELISA kit ¹× ELISA ½Ã±×³ÎÀ» ³ôÇôÁÖ´Â ¹öÆÛµî¿¡ ´ëÇÑ ÀÚ·á°¡ ¼ö·ÏµÈ ¹Ì´ÏīŻ·Î±× ÀÔ´Ï´Ù.
°í¸¶¿¡¼ Ãë±ÞÇÏ´Â PCR °ü·Ã ¸ðµç Á¦Ç°µéÀÌ ¼ö·ÏµÈ ¹Ì´ÏīŻ·Î±× ÀÔ´Ï´Ù.
°í¸¶¿¡¼ Ãë±ÞÇÏ´Â ´Ü¹éÁú Àü±â¿µµ¿°ú ÇÙ»ê Àü±â¿µµ¿¿¡ »ç¿ëµÇ´Â ÀåÄ¡¸¦ ºñ·ÔÇÏ¿©, pre-cast gel, Marker, °¢Á¾ reagentµéÀÌ ¼Ò°³µÇ¾î ÀÖ´Â ¹Ì´Ï Ä«´Þ·Î±×ÀÔ´Ï´Ù.
KOMA¿¡¼ Ãë±ÞÇÏ´Â Neuroscience°ü·Ã cell°ú kits, ½Å°æÁúȯ °ü·Ã Ç×ü¿Í biochemical, ion channel, GPCR Á¦Ç°µéÀÌ ¼Ò°³µÇ¾î ÀÖ´Â ¹Ì´Ï Ä«´Þ·Î±×ÀÔ´Ï´Ù.
Luminex, Milliplex kit, ºÐ¼® ¼ºñ½º ³»¿ëÀ» ¼Ò°³ÇÕ´Ï´Ù.
2012³â 1ºÐ±â ¾÷µ¥ÀÌÆ® µÈ Multiplex Magnetic Bead KitÀ» ¼Ò°³ÇÕ´Ï´Ù.
Kidney injury¿¡ °ü·ÃµÈ Urinary biomarker Multiplex kitÀ» ¼Ò°³ÇÕ´Ï´Ù.
Luminex¸¦ ÀÌ¿ëÇÑ signaling pathway ºÐ¼®À» ¼Ò°³ÇÕ´Ï´Ù.
Luminex¸¦ ÀÌ¿ëÇÑ Cytokine ºÐ¼®À» ¼Ò°³ÇÕ´Ï´Ù.
G-Protein assay¿¡ ÇÊ¿äÇÑ ELISA ŸÀÔÀÇ Å¶À» ¼Ò°³ÇÕ´Ï´Ù.
NGF, BDNF, GDNF Á¦Ç°ÀÇ ½ÇÇèÁ¤º¸¿Í ÇÔ²² »õ·Î¿î Neutrophic factorÁ¦Ç°µéÀ» ¼Ò°³ÇÕ´Ï´Ù.
Neuroscience¿¡ ÇÊ¿äÇÑ Antibody, Assay KitµîÀ» ¼Ò°³ÇÕ´Ï´Ù.
Lead compound screening ¹× Biopharma ºÐ¼®¹æ¹ý°ú ¼ºñ½º¸¦ ¼Ò°³ÇÕ´Ï´Ù.
Lead compound screeningÀ» À§ÇÑ ´Ù¾çÇÑ ºÐ¼®¹æ¹ý°ú ¼ºñ½º¸¦ ¼Ò°³ÇÕ´Ï´Ù.
Cardiac Safety¸¦ ÃøÁ¤Çϴµ¥ ÇÊ¿äÇÑ hERG (Cardiac profiler) Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
GPCR¿¡ ´ëÇÑ CompoundÀÇ activity ÃøÁ¤À» ¼Ò°³ÇÕ´Ï´Ù.
PI3 Kinase¿¡ ´ëÇÑ CompoundÀÇ activity ÃøÁ¤À» ¼Ò°³ÇÕ´Ï´Ù.
Lipid Kinase¿¡ ´ëÇÑ CompoundÀÇ activity ÃøÁ¤À» ¼Ò°³ÇÕ´Ï´Ù.
Ion channel target¿¡ ´ëÇÑ CompoundÀÇ activity ÃøÁ¤À» ¼Ò°³ÇÕ´Ï´Ù.
GPCR study¿¡ ÇÊ¿äÇÑ GPCR Antibody¸¦ ¼Ò°³ÇÕ´Ï´Ù.
Drug Discovery¿¡ ÇÊ¿äÇÑ High Quality Cell LineÀ» ¼Ò°³ÇÕ´Ï´Ù.
125 validated human GPCR membrane preparations
´Ù¾çÇÑ ºÐ¾ßÀÇ Ç×ü ¹× WB°ü·ÃÁ¦Ç°, Cell Counter, cytokine multiplexÁ¦Ç°µîÀ» ¼Ò°³ÇÕ´Ï´Ù.
Biological sample¿¡ Á¸ÀçÇÏ´Â °¢Á¾ Circulating biomarkerÀÇ ¾çÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ELISA kit ÀÔ´Ï´Ù.
signaling research¿Ü¿¡µµ ´Ü¹éÁú ¿¬±¸ºÐ¾ß¿¡ ÇÊ¿äÇÑ ´Ù¾çÇÑ Á¦Ç°µéÀÌ ¼Ò°³µÇ¾î ÀÖ½À´Ï´Ù.
WB¿¡ ÇÊ¿äÇÑ blocking buffer, HRP solutionµî »õ·Î¿î Á¤º¸¸¦ ´ã¾Ò½À´Ï´Ù.
Signaling study¿¡ ÇÊ¿äÇÑ Antibody, Assay KitµîÀ» ¼Ò°³ÇÕ´Ï´Ù.
Chemokine, Integrin, Cytokine Receptorsµî¿¡ ´ëÇÑ agonist, antagonist, inhibitorµîÀ» ¼Ò°³ÇÕ´Ï´Ù.
SNAP i.d.¸¦ ÀÌ¿ëÇÑ WB ¹æ¹ýÀ» ¼Ò°³ÇÕ´Ï´Ù.
retinoid receptorÀÇ pharmacological review¸¦ Á¦°øÇÕ´Ï´Ù.
2011³â »ó¹Ý±â¿¡ Ãß°¡µÈ Tocris ½ÅÁ¦Ç° ¸ñ·ÏÀÔ´Ï´Ù.
MAPKs activation¿¡ ¼ö¹ÝµÈ ¿©·¯ ´Ü¹éÁúÀÇ ÀλêÈ¿Í inhibitorµî¿¡ ´ëÇÑ ÀڷḦ Á¦°øÇÕ´Ï´Ù.
P2 receptors family¿¡ ´ëÇÑ agonist, antagonist Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
5-HT receptors family¿¡ ´ëÇÑ agonist, antagonist Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
GABA receptor subtypes°ú ligandsÀÇ ±¸Á¶¿Í ±â´É¿¡ ´ëÇÑ review¸¦ Á¦°øÇÕ´Ï´Ù.
½Ä¿åÁ¶Àý°ú ¿¡³ÊÁö Çâ»ó¼º¿¡ °ü·ÃÇÑ ÆéŸÀ̵åµéÀÇ °³¿ä¸¦ Á¦°øÇÕ´Ï´Ù.
Dopamine receptor subtypeÀÇ ¿ä¾à ¹× ligand¿¡ ´ëÇÑ °¡À̵带 Á¦°øÇÕ´Ï´Ù.
¿©·¯Á¾·ùÀÇ histamine receptor subtype°ú ligand¿¡ ´ëÇÑ °³¿ä¸¦ Á¦°øÇÕ´Ï´Ù.
nAChRsÀÇ ¿¬±¸¿¡ °ü·ÃµÈ overview¸¦ Á¦°øÇÕ´Ï´Ù.
°¡Àå ±¤¹üÀ§ÇÏ°Ô ¿¬±¸µÇ´Â ligand¿¡ ´ëÇÑ review¸¦ Á¦°øÇÕ´Ï´Ù.
mGluRÀÇ pharmacological review¸¦ Á¦°øÇÕ´Ï´Ù.
250¿©°¡ÁöÀÇ Peptide, Steroid Hormone, Insulin, Hypothalamic ReceptorsµîÀ» ¼Ò°³ÇÕ´Ï´Ù.
stem cell proliferation°ú differentiation¿¡ °ü¿©ÇÏ´Âcompound¿¡ ´ëÇÑ review¸¦ Á¦°øÇÕ´Ï´Ù.
Human Stem Cell ¿¬±¸¿¡ ÇÊ¿äÇÑ cell, kit, media, Ç×üµîÀ» ¼Ò°³ÇÕ´Ï´Ù.
Stem Cell ¿¬±¸¿¡ ÇÊ¿äÇÑ media, cell line, kitµî ´Ù¾çÇÑ ÀÚ·á°¡ ¼ö·ÏµÇ¾î ÀÖ½À´Ï´Ù.
30Ãʸ¸¿¡ ¼¿Ä«¿îÆÃÀ» ³¡³¾¼ö ÀÖ´Â ÈÞ´ë¿ë cell counter Çѱۺê·Î¼Å·Î ÇÑÃþ ´õ ¾÷±×·¹ÀÌµÈ Á¦Ç°Á¤º¸°¡ ¼Ò°³µÇ¾î ÀÖ½À´Ï´Ù.
RNA¸¦ extract ÇϱâÀ§ÇÑ RIP Kit¿Í RIP validated Ç×ü¿¡ ´ëÇÑ ÀÚ·áÀÔ´Ï´Ù.
hallmark¿¡¼ biomarker±îÁö, cancer research¿¡ ÇÊ¿äÇÑ Á¦Ç°¸®½ºÆ®¸¦ ¼Ò°³ÇÕ´Ï´Ù.
Antibodies, Proteins, Kits, and Assays
p53 tumour suppressor response¿¡ ´ëÇÑ Á¤º¸¸¦ ´ã¾Ò½À´Ï´Ù.
cell signaling¿¡ ÇÊ¿äÇÑ 20¿©°¡ÁöÀÇ pathway¸¦ ´ã¾Ò½À´Ï´Ù.
DNA damage¿¡ ´ëÇÑ checkpoint kinase signaling network response¸¦ ´ã¾Ò½À´Ï´Ù.
Alzheimer's Disease¿¡ ´ëÇÑ Á¤º¸¸¦ ´ã¾Ò½À´Ï´Ù.
G-protein dependent ¹× independent ½Ã±×³Îµî 7-TM (Seven Transmembrane)ÀÇ action¿¡ ´ëÇÑ pathway¸¦ ´ã¾Ò½À´Ï´Ù.
Stroke, Trauma, Neurodegeneration¿¡ ´ëÇÑ neuroprotective signalÀ» ´ã¾Ò½À´Ï´Ù.
¼ÒÈ, ½Ä¿åµî¿¡ °ü·ÃµÈ neuropeptide modulator¿¡ ´ëÇÑ pathway¸¦ ´ã¾Ò½À´Ï´Ù.
Synaptic Structure pathway¸¦ ´ã¾Ò½À´Ï´Ù.
Alzheimer¡¯s Mechanism pathway¸¦ ´ã¾Ò½À´Ï´Ù.
Human Ion Channelome Á¤º¸¸¦ ´ã¾Ò½À´Ï´Ù.
Human GPCRome Á¤º¸¸¦ ´ã¾Ò½À´Ï´Ù.
Human Kinome Á¤º¸¸¦ ´ã¾Ò½À´Ï´Ù.
COPYRIGHT(c) 2008. °í¸¶¹ÙÀÌ¿ÀÅØ(ÁÖ). ALL RIGHTS RESERVED. Contact Webmaster for more information. ¼¿ï½Ã °¼±¸ °¡¾ç3µ¿ 1487¹øÁö °¡¾çÅ×Å©³ëŸ¿î 301È£ | TEL 02)579-8787 | FAX 02)578-7042. (¼¿ï½Ã °¼±¸ ÇãÁØ·Î 217 °¡¾çÅ×Å©³ëŸ¿î 301È£)